|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Articles in PresS, published online ahead of print July 30, 2002
Am J Physiol Endocrinol Metab, 10.1152/ajpendo.00205.2001
Submitted on May 14, 2001
Accepted on July 9, 2002
1 Department of Internal Medicine, Erasmus Medical Center, Rotterdam, The Netherlands; Department of Endocrinological and Metabolic Sciences, University of Genova, Genova, Italy
2 Department of Internal Medicine, Erasmus Medical Center, Rotterdam, The Netherlands; Department of Molecular and Clinical Endocrinology and Oncology, University of Naples, Naples, Italy
3 Department of Internal Medicine, Erasmus Medical Center, Rotterdam, The Netherlands; Department of Immunology, Erasmus Medical Center, Rotterdam, The Netherlands
4 Department of Internal Medicine, Erasmus Medical Center, Rotterdam, The Netherlands
5 Department of Molecular and Clinical Endocrinology and Oncology, University of Naples, Naples, Italy
6 Department of Endocrinological and Metabolic Sciences, University of Genova, Genova, Italy
* To whom correspondence should be addressed. E-mail: ferone{at}unige.it.
We recently demonstrated the expression of somatostatin (SS) and SS receptor (SSR) subtype 1 (sst1), sst2A and sst3 in normal human thymic tissue and of sst1 and sst2A on isolated thymic epithelial cells (TEC). We also found an inhibitory effect of SS and octreotide on TEC proliferation. In the current study we further investigated the presence and function of SSR in freshly purified human thymocytes at various stages of development. Thymocytes represent a heterogeneous population of lymphoid cells displaying different levels of maturation and characterized by specific cell surface markers. In the this study, we firstly demonstrated specific high affinity [125I-Tyr11]-SS-14 binding on thymocyte membrane homogenates. Subsequently, by RT-PCR, sst2A and sst3 mRNA expression was detected in the whole thymocyte population. After separation of thymocytes into subpopulations, we found by quantitative RT-PCR that sst2A and sst3 are differentially expressed in intermediate/mature and immature thymocytes. The expression of sst3 mRNA was higher in the intermediate/mature CD3+ fraction compared with the immature CD2+CD3- one, while sst2A mRNA was less abundant in the intermediate/mature CD3+ thymocytes. In 7 days cultured thymocytes SSR subtype mRNA expression was lost. SS-14 significantly inhibited 3H-Thymidine incorporation in all thymocyte cultures, indicating the presence of functional receptors. Conversely, octreotide significantly inhibited 3H-Thymidine incorporation only in the cultures of immature CD2+CD3- thymocyte. Sst3 is mainly expressed on intermediate/mature thymocyte fraction and most of these cells generally die by apoptosis. Since SS-14, but not octreotide,induced a significant increase in the percent of apoptotic thymocytes, it might be that sst3 is involved in this process. Moreover, sst3 has been recently demonstrated on peripheral human T lymphocytes, which directly derive from mature thymocytes, and SS analogs may induce apoptosis in these cells. Interestingly, CD14+ thymic cells, which are cells belonging to the monocytes-macrophage lineage, selectively expressed sst2A mRNA. Finally, SSR expression in human thymocytes seems to follow a developmental pathway. The heterogeneous expression of SSR within the human thymus on specific cell subsets and the endogenous production of SS as well as SS-like peptides emphasize their role in the bi-directional interactions between the main cell components of the thymus involved in intrathymic T-cell maturation.
This article has been cited by other articles:
![]() |
G. Vitale, W. W. de Herder, P. M. van Koetsveld, M. Waaijers, W. Schoordijk, E. Croze, A. Colao, S. W.J. Lamberts, and L. J. Hofland IFN-{beta} Is a Highly Potent Inhibitor of Gastroenteropancreatic Neuroendocrine Tumor Cell Growth In vitro Cancer Res., January 1, 2006; 66(1): 554 - 562. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. van der Hoek, M. Waaijers, P. M. van Koetsveld, D. Sprij-Mooij, R. A. Feelders, H. A. Schmid, P. Schoeffter, D. Hoyer, D. Cervia, J. E. Taylor, et al. Distinct functional properties of native somatostatin receptor subtype 5 compared with subtype 2 in the regulation of ACTH release by corticotroph tumor cells Am J Physiol Endocrinol Metab, August 1, 2005; 289(2): E278 - E287. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| Visit Other APS Journals Online |